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Introduction: Due to the complexity of the surgical procedure portal vein thrombosis (PVT) has long been
considered an absolute contraindication to liver transplantation (LT). The presence of a large splenorenal
shunt (SRS) could make portal anastomosis a valid option.
Presentation of case: We report the case of a 37-year-old female patient with Grade III PVT and a large
SRS, who underwent orthotopic LT. Liver was implanted using a 1992-Belghiti piggyback technique and
portal anastomosis was performed using the large spleno-renal shunt. We observed good graft reper-
fusion and postoperative Doppler ultrasound showed normal portal vein flow. She was discharged on
postoperative day 7, with an excellent graft function. At six months follow-up, patient is alive with
normal hepatic vascularization.
Discussion: Due to paucity of reports, there is currently no consensus on the indication to LT and/or
surgical technique. In the present case, once the transplant benefit was evaluated, the Grade III PVT was
not considered a contraindication to LT.
Conclusion: The presence of a Grade III PVT associated with a large SRS should not be considered a
contraindication for LT, and the use of the shunt vein should be considered a feasible option to perform
portal anastomosis.
© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Portal vein thrombosis (PVT) is a complication of chronic liver
disease. It is typically associated with portal vein hypertension and
porta-cava shunts, with the formation of venous collaterals that, liver transplantation; SRS,
ICU, Intensive Care Unit; LRV,
ier Ltd on behalf of IJS Publishingbypass the narrowed or occluded portal vein, forming ‘surrounding
portal vein cavernoma’ or spontaneous real anatomical porto-
systemic shunts. Of these shunts, the most common, with a prev-
alence of 20e35% in liver transplantation (LT) candidates [1] is the
splenorenal shunt (SRS).
Although PVT has long been considered an absolute contrain-
dication to LT, it is currently regarded as a relative contraindication,
depending on the type of PVT, patient clinical status, and obviously,
the surgeon's experience. In the year 2000, the Birmingham Group
graded PVT according to operative findings, as shown in Table 1 [2].
If, on the one hand, the natural SRS protects from variceal devel-
opment by avoiding fatal bleeding, on the other, it complicatesGroup Ltd. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Birmingham Group Classification of Portal Vein Trombosis findings during liver transplant procedure [2].
Yerdel grade Description
I Minimally or partially thrombosed PV, in which the thrombus is mild or, at the most, confined to 50% of the vessel lumen with or without minimal
extension into the SMV
II >50% occlusion of the PV, including total occlusions, with or without minimal extension into the SMV
III Complete thrombosis of both PV and proximal SMV. Distal SMV is open.
IV Complete thrombosis of the PV and proximal as well as distal SMV
SMV: superior mesenteric vein; PV: portal vein.
Fig. 2. Spleno-renal shunt after surgeon dissection. On the blue vessel loop the splenic
and renal side of the shunt SRS: spleno-renal shunt; GB: Gallbladder; L: Liver.
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preparation of the shunt.
We report the case of a young patient with pre-operative Grade
III PVT, associated with SRS, who subsequently underwent LT for
autoimmune cirrhosis. The present case is in line with the CARE
criteria [3]. We searched for published studies that described LT in
recipients with preoperative PVT Grade III or IV in PubMed (http://
www.ncbi.nlm.nih.gov/pubmed).
2. Presentation of case
A 37-year-old female patient with autoimmune hepatitis/pri-
mary biliary cirrhosis overlap syndrome underwent deceased-
donor LT. Pre-operative computed tomography (CT) scan showed
extensive thrombosis of the portal vein extending to the origin of
the SMV [Yerdel Grade 3 (2)], with severe porto-systemic collateral
veins, including a SRS > 1 cm in diameter (Fig. 1). At the time of LT,
the Model End-Stage Liver Disease score was 24 and the Mayo Risk
Score was 9.0.
After right subcostal incision, we accessed the omentum retro-
cavity in order to expose the large SRS and verify the usability of the
vein so as to safely perform a portal venous shunt anastomosis.
Since a calcific portal vein sclerosis extending into the proximal
superior mesenteric vein was confirmed, portal trombectomy was
ruled out; hence the proximal (splenic side) and distal (renal side)
SRS were prepared circumferentially and the small vessels arising
from the shunt ligated (Fig. 2). We performed the transplant pro-
cedure using a 1992-Belghiti piggyback technique [4]. The SRS was
sectioned at the confluence to the left renal vein after side to sideFig. 1. Preoperative Radiological Imaging 3D. In white, the massive and tortuous shunt
arising from splenic and reaches left renal vein. PVT: portal vein trombosis.vena cava anastomosis and the renal side was brought behind the
stomach (Fig. 3); A running suture, with a 5/0 prolene stitch, was
used to perform a T-Tanastomosis between portal vein and venous-
shunt (Fig. 4). We observed good graft reperfusion without surgical
or medical problems. The intraoperative Doppler ultrasoundFig. 3. The “spleno-renal shunt stump”. The shunt sectioned at the confluence of left
renal vein was brought behind to the stomach to safely perform portal anastomosis. S:
Stomach; SRSt: Spleno renal stump; SRS: spleno-renal shunt.
Fig. 4. Portal anastomosis. The portal vein was anastomosed to the renal side of the
shunt vein using a 5-0 prolene running suture. DPV: Donor Portal Vein; BD: Bile Duct;
HA: Hepatic Artery.
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The cold ischemic time was 5.40 hours and warm ischemic time
was 50 minutes. Total operative time was 7 hours. During the
operation the patient required transfusion of three red blood cell
units and eight fresh plasma units. The patient was kept in the
Intensive Care Unit (ICU) 24 hours. Post-operative course was un-
eventful and the liver ultrasounds performed at 1, 3 and 7 post-
operative days were comparable to intra-operative sonography.
Subcutaneous lowmolecular weight heparin was given from day 1,
at dosage of 4000 UI/day, in order to prevent portal thrombosis.
Patient was discharged on postoperative day 7 with excellent graft
function. After hospital discharge, the patient was treated with
warfarin at starting dose of 5mg and the therapywas adjusted after
outpatient visit to maintain PT-INR between 2 and 3.
Eight months after LT, the patient is in good clinical condition
with normal portal flow.
3. Discussion
In the early 1990s, PVT ceased to be considered a contraindi-
cation for LT [6]. Although most authors agree that there is no
contraindication for Grades I-II, the procedure is questionable in
patients with advanced PVT (Grade III and IV); this condition, in
fact, increases mortality and morbidity rate during or immediately
after LT by 50%, thus excluding LT in these candidates [2e7]. PVT
has been associated with increased operative times, more red blood
cell transfusions, higher rate of reoperation, longer ICU and hospital
stays [8]. Currently there is no standard surgical technique for
performing LT in PVT patients; jump vascular graft with venous
conduit, renal-portal anastomosis or cavo-portal hemi-trans-
position are surgical options available for managing PVT discovered
during surgery [9]. In fact, although a complete vascular evaluation
with CT-scan is usually performed before LT, nearly half of PVTcases
are found accidentally during the LT procedure [10].
In the context of greatly advanced cirrhosis, the incidence of SRS
is approximately 30% [11]. Management of SRS remains contro-
versial, as there is still no consensus on indications to LT and mo-
dalities of care. When PVT is associated with a large SRS,
splenectomy and Portal-SRS anastomosis represent a therapeutic
option in case of hypersplenism, in order to avoid postoperative
portal steal syndrome and ensure an adequate flow to the liver.
Other authors suggest the ligation of left renal vein (LRV) and
portal-renal anastomosis as an option to overcome complete
mesenteric-portal thrombosis [12e14].In our case, the preoperative enhanced CT-scan clearly showed
Grade III PVT and SRS. A multidisciplinary meeting (including a
radiologist, a hepatologist and a transplant surgeon) was held to
evaluate the pros and cons of liver transplantation. Given the age of
the patient (37 years), and the 20% estimated survival expectancy
without transplantation (according to Mayo Clinic Risk score,www.
mayoclinic.org) the patient was put on the Regional Liver Transplant
waiting list despite surgical complexity and the intra- and post-
operative risks, During surgery, given the presence of a large
shunt and good blood flow towards to the left renal vein (confirmed
by intraoperative sonography), we followed the vein to the renal
side. A second check on flow direction was performed after
clamping the shunt at mid-length, noting the deflation of the shunt
on the renal side and a greater filling on the splenic side. We
therefore decided to preserve the renal vein and perform the
anastomosis on the renal side of the shunt; moreover, since there
was no hypersplenism, splenectomy was avoided, thus preventing
immune damage and other surgical complications [13].4. Conclusion
Since nowadays there is no surgical consensus on portal revas-
cularization in case of Grade III-IV PVT, the use of SRS for portal
anastomosis on the renal shunt side could represent a valid option,
once flow direction has been confirmed by intraoperative
ultrasound.
Cases with unusable portal veins in the context of large
retroperitoneal-shunt development should not necessarily be
considered a contraindication to LT. A multidisciplinary meeting
including liver surgeons, radiologists and hepatologist is crucial to
evaluate both the feasibility of surgery and transplant benefit.
Finally, liver transplantation surgery in the PVT setting must always
be led by a highly experienced liver transplant surgeon, due to the
complexity of the surgery involved.Ethical Approval
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